StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Last viewed:
abus
Prices are updated after-hours
Sector
Health Technology
1
Industry
Biotechnology
1
Name
Arbutus Biopharma Corporation
1
Symbol
Abio
1
Abnb
1
Abos
1
Abus
1
Acnb
1
Acrs
1
Actg
1
Acva
1
Aehr
1
Aei
1
Afrm
1
Ahpi
1
Aktx
1
Alec
1
Altr
1
Amed
1
Apen
1
Aqb
1
Atax
1
Atcx
1
Atos
1
Aubn
1
Avnw
1
Axti
1
Bbby
1
Beam
1
Bimi
1
Bl
1
Blcm
1
Blfs
1
Brqs
1
Bsgm
1
Bsqr
1
Bsy
1
Bwfg
1
Carg
1
Cccc
1
Cdmo
1
Cdna
1
Cdzi
1
Celh
1
Ceva
1
Cfms
1
Clbk
1
Clir
1
Clsk
1
Cmax
1
Cntg
1
Conn
1
Cprt
1
Cpss
1
Crnt
1
Cron
1
Crox
1
Crwd
1
Ctxr
1
Cvrx
1
Ddi
1
Dffn
1
Dgly
1
Tags
Hepatitis
1
Injection
1
Venue
Nasdaq
1
Ipo Year
N::a
1
Country
United States
1
Sec Forms
10-k
1
10-k::a
1
10-q
1
3
1
4
1
424b5
1
8-k
1
Corresp
1
Ct Order
1
Def 14a
1
Defa14a
1
Effect
1
S-3
1
S-8
1
Sc 13g
1
Sc 13g::a
1
Upload
1
Sec Forms Date
2021 - 08 - 05
1
2021 - 07 - 14
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 06 - 07
1
2021 - 06 - 01
1
2021 - 05 - 05
1
2021 - 04 - 08
1
2021 - 04 - 01
1
2021 - 03 - 16
1
2021 - 03 - 04
1
2021 - 02 - 26
1
2021 - 02 - 17
1
2021 - 02 - 16
1
2021 - 02 - 12
1
2021 - 02 - 10
1
2021 - 02 - 01
1
2021 - 01 - 25
1
2020 - 12 - 16
1
2020 - 12 - 10
1
2020 - 11 - 16
1
2020 - 11 - 05
1
2020 - 10 - 22
1
2020 - 10 - 21
1
2020 - 09 - 25
1
2020 - 09 - 15
1
2020 - 09 - 03
1
2020 - 09 - 01
1
2020 - 08 - 28
1
2020 - 08 - 27
1
2020 - 08 - 10
1
2020 - 08 - 07
1
2020 - 07 - 27
1
2020 - 07 - 24
1
2020 - 07 - 23
1
2020 - 07 - 16
1
2020 - 06 - 24
1
2020 - 06 - 01
1
2020 - 05 - 18
1
2020 - 05 - 11
1
2020 - 04 - 24
1
2020 - 03 - 26
1
2020 - 03 - 06
1
2020 - 03 - 05
1
2020 - 02 - 19
1
2020 - 02 - 14
1
2020 - 02 - 10
1
2020 - 01 - 13
1
2020 - 01 - 10
1
2020 - 01 - 08
1
2019 - 12 - 27
1
2019 - 12 - 23
1
2019 - 12 - 09
1
2019 - 11 - 06
1
2019 - 11 - 05
1
2019 - 10 - 03
1
2019 - 08 - 26
1
2019 - 08 - 20
1
News In 15d
1
1
News In 30d
3
1
Created At
2020 - 11 - 27
1
Abus
Nasdaq
2021 - 07 - 07
Arbutus Biopharma Corporation
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
(
0.0%
1d)
(
15.0%
1m)
(
-1.0%
1y)
(
0.0%
2d)
(
-1.7%
3d)
(
-3.6%
7d)
(
-82.24%
volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 500,783,235
http://www.arbutusbio.com
Sec Filling
|
Patents
| 80 employees
ABUS
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis
injection
add to watch list
Paper trade
email alert is off
Press-releases
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published:
2024-04-04
(Crawled : 12:30)
- globenewswire.com
MRNA
|
News
S
|
$103.45
-0.33%
-0.33%
2M
|
Health Technology
|
2.55%
|
O:
1.46%
H:
3.2%
C:
-0.41%
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
16.33%
|
O:
16.73%
H:
6.14%
C:
2.39%
patent
construction
biopharma
ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published:
2024-03-20
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
15.42%
|
O:
-1.58%
H:
3.05%
C:
2.41%
year
update
financial
results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published:
2024-03-18
(Crawled : 14:00)
- prnewswire.com
CVAC
|
$2.57
-3.57%
-3.7%
920K
|
Health Technology
|
-19.24%
|
O:
0.0%
H:
0.0%
C:
-2.73%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-6.64%
|
O:
0.48%
H:
1.18%
C:
0.08%
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
11.45%
|
O:
0.38%
H:
0.38%
C:
-3.42%
report
genomic
market
Arbutus to Participate in Two Upcoming Investor Conferences
Published:
2024-03-08
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
6.18%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published:
2024-03-08
(Crawled : 14:30)
- biospace.com/
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
6.18%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published:
2024-02-29
(Crawled : 12:30)
- globenewswire.com
ROIV
|
$10.45
-2.43%
-2.49%
4M
|
Manufacturing
|
-8.54%
|
O:
1.2%
H:
0.34%
C:
-3.46%
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
0.34%
|
O:
-1.37%
H:
0.0%
C:
-2.44%
year
update
financial
results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published:
2024-02-15
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
-0.17%
|
O:
0.85%
H:
0.0%
C:
-1.36%
report
year
update
financial
results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
21.16%
|
O:
3.32%
H:
3.21%
C:
-1.61%
update
financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published:
2023-11-09
(Crawled : 21:00)
- globenewswire.com
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
62.22%
|
O:
1.67%
H:
0.0%
C:
-3.28%
hbv003
biopharma
collaboration
trial
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
Published:
2023-11-09
(Crawled : 21:00)
- globenewswire.com
ABUS
|
$2.79
-4.45%
-4.66%
710K
|
Health Technology
|
62.22%
|
O:
1.67%
H:
0.0%
C:
-3.28%
vtp-300
meeting
liver
biopharma
trial
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
380500
380500
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
95100
95100
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
403900
403900
0001447028-24-000028
4
2024-02-06
2024-02-02
Sell
S
4358
125542
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
101000
129900
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Last 48 Hours Insiders Buying
IZEA
|
$2.5
-2.4%
8.6K
|
Technology Services
|
00:00
RKT
P
383
|
$11.38
-0.52%
1.05%
1.4M
|
Finance
|
22:30
CTRN
P
18090
|
$22.46
-1.01%
-1.02%
55K
|
Retail Trade
|
22:00
BRN
P
10650
|
$2.795
2.38%
0.18%
35K
|
Energy Minerals
|
21:00
NEOG
P
10000
|
$12.14
-0.16%
-0.16%
3.1M
|
Health Technology
|
16:30
RMCF
|
$3.51
-3.7%
-3.85%
3.8K
|
Consumer Non-Durables
|
20:10
12 months watchlist earnings calendar